Conference abstract · 20 Nov 2013
Conference abstractPublished 9 Nov 2017
Identification and characterization of molecular targets of Tris DBA [tris(dibenzylideneacetone) dipalladium (0)] for cancer therapy
Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cellworks Group Inc, USA
Abstract
Cancer is complex disease involving complex genetic and epigenetic heterogeneity making it the second leading cause of mortality globally after cardiovascular disorders. While conventional treatments like surgery, radiotherapy, chemotherapy remain principal treatment strategies, the focus is gradually shifting towards anti-cancer therapies that can target multiple oncogenic pathways simultaneously. In the present report, we hypothesized that Tris DBA, an organopalladium compound, might inhibit proliferation, invasion and migration, and induce apoptosis in multiple myeloma (MM) and hepatocellular carcinoma (HCC) cells, thereby potentially exhibiting a broad spectrum of anticancer effects. Our preliminary results indicate that Tris DBA could substantially inhibit both constitutive and IL-6 inducible STAT3 activation and abrogate proliferation/ survival of MM/HCC cells without displaying any adverse side effects in nu/nu mice. In future work, we aim to investigate the possible molecular targets of Tris DBA and further characterize the molecular mechanism(s) underlying its STAT3 inhibitory effects in both MM and HCC cells.
Subjects
BiologySimilar by topic
Conference abstract · 9 Nov 2017
The potential molecular targets of Fangchinoline for cancer therapy
Conference abstract · 8 May 2017
STAT3 as a molecular target for prostate cancer prevention and therapy
Conference abstract · 13 Sep 2021
Using molecular dynamics simulation to study hydrogen bond in 1-n-Alkyl-3- methylimidazolium tris(pentafluoroethyl)trifluorophosphate ionic liquids
Research article · 3 May 2019
Synthesis and characterization tris N-2,4-dinitrophenyl N/-3-nitrobenzylidenehydrazine palladium chloride and tris N-2,4- dinitrophenyl N/-3-phenyl alilidine hydrazine
More from this journal
The newest in Current Synthetic and Systems Biology.
Research article · 25 Aug 2026
Reduction of Circulating Microplastic Burden in Companion Dogs Following Administration of a Food-Grade Plastic Adsorptive Compound: A Preliminary Case Series
Commentary · 30 Dec 2025
Synthetic Organelles Driving Innovation in Biotechnology and
Opinion · 30 Dec 2025
XNAs And The Evolution Of Synthetic Genetic Design
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCurrent Synthetic and Systems Biology
- SubjectBiology
- BylineArticles whose byline prints “Loukik Arora”
- BylineArticles whose byline prints “Shireen Vali”
- BylineArticles whose byline prints “Taher Abbasi”
- BylineArticles whose byline prints “Alan Prem Kumar”
- BylineArticles whose byline prints “Gautam Sethi”

